| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |